Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12471-013-0462-3
DC FieldValue
dc.titlePlasma extra cellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease
dc.contributor.authorWang, J.W
dc.contributor.authorGijsberts, C.M
dc.contributor.authorSeneviratna, A
dc.contributor.authorDe Hoog, V.C
dc.contributor.authorVrijenhoek, J.E.P
dc.contributor.authorSchoneveld, A.H
dc.contributor.authorChan, M.Y
dc.contributor.authorLam, C.S.P
dc.contributor.authorRichards, A.M
dc.contributor.authorLee, C.N
dc.contributor.authorMosterd, A
dc.contributor.authorSze, S.K
dc.contributor.authorTimmers, L
dc.contributor.authorLim, S.K
dc.contributor.authorPasterkamp, G
dc.contributor.authorde Kleijn, D.P.V.
dc.date.accessioned2020-09-04T06:35:03Z
dc.date.available2020-09-04T06:35:03Z
dc.date.issued2013
dc.identifier.citationWang, J.W, Gijsberts, C.M, Seneviratna, A, De Hoog, V.C, Vrijenhoek, J.E.P, Schoneveld, A.H, Chan, M.Y, Lam, C.S.P, Richards, A.M, Lee, C.N, Mosterd, A, Sze, S.K, Timmers, L, Lim, S.K, Pasterkamp, G, de Kleijn, D.P.V. (2013). Plasma extra cellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. Netherlands Heart Journal 21 (10) : 467-471. ScholarBank@NUS Repository. https://doi.org/10.1007/s12471-013-0462-3
dc.identifier.issn15685888
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174444
dc.description.abstractCardiovascular disease is a major public health problem worldwide. Its growing burden is particularly ominous in Asia, due to increasing rates of major risk factors such as diabetes, obesity and smoking. There is an urgent need for early identification and treatment of individuals at risk of adverse cardiovascular events. Plasma extra cellular vesicle proteins are novel biomarkers that have been shown to be useful in the diagnosis, risk stratification and prognostication of patients with cardiovascular disease. Ongoing parallel bio bank initiatives in European (the Netherlands) and Asian (Singapore) populations offer a unique opportunity to validate these biomarkers in diverse ethnic groups. © The Author(s) 2013.
dc.publisherICIN
dc.sourceUnpaywall 20200831
dc.subjectbiological marker
dc.subjectblood clotting factor 10
dc.subjectblood clotting factor 7a
dc.subjectblood clotting factor 9
dc.subjectCD14 antigen
dc.subjectCD31 antigen
dc.subjectcomplement component C5a
dc.subjectcystatin C
dc.subjectlipocortin 5
dc.subjectmicroRNA
dc.subjectP selectin glycoprotein ligand 1
dc.subjectprocoagulant
dc.subjectthromboplastin
dc.subjectacute coronary syndrome
dc.subjectarticle
dc.subjectAsian
dc.subjectcardiovascular disease
dc.subjectCaucasian
dc.subjectcoronary artery bypass graft
dc.subjectdiabetes mellitus
dc.subjectendothelium cell
dc.subjectexosome
dc.subjectgender
dc.subjectheart infarction
dc.subjecthuman
dc.subjectobesity
dc.subjectpercutaneous coronary intervention
dc.subjectplasma
dc.subjectprognosis
dc.subjectprotein content
dc.subjectpublic health problem
dc.subjectrisk factor
dc.subjectsmoking
dc.subjectthrombogenicity
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.contributor.departmentSURGERY
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1007/s12471-013-0462-3
dc.description.sourcetitleNetherlands Heart Journal
dc.description.volume21
dc.description.issue10
dc.description.page467-471
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1007_s12471-013-0462-3.pdf321.79 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.